Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
FranceA study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism
GermanyA study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata
BulgariaA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
BulgariaA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
AustriaA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
AustriaA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
BelgiumA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
BelgiumA study to evaluate the effectiveness and safety of usnoflast in adults with Amyotrophic Lateral Sclerosis (ALS)
BelgiumStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
AustriaStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
BelgiumStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
